首页> 美国卫生研究院文献>British Journal of Cancer >Clinical implications of expression of vascular endothelial growth factor in metastatic lesions of ovarian cancers
【2h】

Clinical implications of expression of vascular endothelial growth factor in metastatic lesions of ovarian cancers

机译:血管内皮生长因子表达在卵巢癌转移性病变中的临床意义

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Vascular endothelial growth factor (VEGF) has been identified as an important factor for tumour angiogenesis, which is essential for the growth, invasion and metastasis of solid tumours. Significantly increased VEGF level from the primary tumour to the metastatic lesion of ovarian cancers was found in 8 of 30 cases. The 24-month survival rate of the patients with significantly increased VEGF level was extremely poor (0/8 = 0%) in comparison with that of patients with no change in the level (15/22 = 68%) from the primary tumour to the metastatic lesion. This indicates that VEGF may contribute to the advancement of metastatic lesions, and that VEGF level in metastatic lesions may be a prognostic indicator. © 2001 Cancer Research Campaign
机译:血管内皮生长因子(VEGF)已被确定为肿瘤血管生成的重要因子,对于实体瘤的生长,侵袭和转移至关重要。从30例病例中有8例发现从原发肿瘤到卵巢癌转移灶的VEGF水平显着增加。与从原发肿瘤到原发肿瘤的水平无变化的患者(15/22 = 68%)相比,VEGF水平显着升高的患者的24个月生存率极差(0/8 = 0%)。转移性病变。这表明VEGF可能有助于转移性病变的发展,转移性病变中的VEGF水平可能是预后的指标。 ©2001癌症研究运动

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号